Q4 2014 EARNINGS REPORT FEBRUARY 26, 2015 South San Francisco, CA February 2015
AGENDA 2014 Business Highlights 2015 Operating Targets Manufacturing Plan and Execution Roquette Arbitration Update Commercial Progress Financial Review and Outlook 3
2014 BUSINESS HIGHLIGHTS Revenue growth 50% Y/Y, product revenue growth 85% Y/Y Expanded Algenist brand and distribution footprint delivering 23% Y/Y growth Launched large-scale commercial operations at Clinton/Galva and Moema…
2015 OPERATING TARGETS Establish consistent and reliable fully integrated operations at Moema Emphasize production of high value products at all facilities Expand commercial traction in targeted products such as AlgaVia & Encapso…
MOEMA: PLAN IN PLACE AND EXECUTING Delivered first runs on a fully integrated basis in December Upstream performing well: produced 1,200MT of dried biomass in December Downstream equipment (oil extraction) working, but optimization…
MOEMA: MILESTONES Key Deliverables to Measure Performance Tie in to redundant supplies of power and steam Receive reliable power/steam supply from co-gen facility Establish fully integrated operations on a consistent basis…
PRODUCTION STRATEGY: OPTIMIZING FOR RETURNS Shift product mix to maximize margin contribution from portfolio of facilities Modest near-term volumes while Moema is optimized Limit production at Clinton/Galva to higher value products…
ROQUETTE ARBITRATION PANEL DECISION The arbitration awarded solely to Solazyme: All Solazyme Roquette Nutritionals patent applications All Solazyme Roquette Nutritionals know-how related to high lipid algal flour and high protein…
COMMERCIAL PROGRESS: ALGAVIA High Oleic food oil recently received FDA GRAS No Questions Letter Full portfolio of initial food products has regulatory clearance for sales SQF certification at Peoria conforms to the Global Food…
ENCAPSO: BROADENING REACH Compelling value proposition: Est. 100k savings per well in North Dakota1 Encapso use expanded to 37 commercial wells in North America Broadening geographic and product applications Commercial well trials…
CONTINUED SUCCESS WITH ALGENIST Continued sales momentum: 2014 up 23% Y/Y Expanded distribution: More than 2,500 stores in 21 countries Broadened line: 34 SKUs including the launch of the new Genius C serum 12
2015 OUTLOOK 2015 Expectations: Revenue growth excluding SB Oils JV (Moema) 15% Y/Y Cash operating expense decrease by 18M Y/Y Capex and SB Oils equity contributions decrease 50% Y/Y or 20-30M 14
POSITIONED TO EXECUTE Clear and focused operating plan for 2015 Peoria & Clinton/Galva are established production facilities Applying experience and expertise from established facilities to Moema Focusing commercial pipeline on…
Loading...
